C Reactive Protein (CRP) Intervention to Reduce Inappropriate Antibiotic Prescriptions in the Primary Healthcare Setting
Launched by OXFORD UNIVERSITY CLINICAL RESEARCH UNIT, VIETNAM · Aug 6, 2013
Trial Information
Current as of July 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients, aged 6 to 65 years, that visit one of the 10 selected primary healthcare centers
- • Suspected to have acute respiratory tract infection (ARI) by treating physician
- • Informed consent
- Exclusion Criteria:
- • Severe respiratory disease as determined by treating doctor
- • Any disease or symptom requiring hospital referral as determined by treating doctor
- • Immunosuppressed patients (e.g. HIV, long term steroid use)
- • Suspicion of tuberculosis
- • Evidence of acute or chronic liver disease (e.g. hepatitis or cirrhosis due to any cause)
- • Past medical history of: neoplastic disease, congestive cardiac failure, chronic obstructive pulmonary disease, insulin-dependent diabetes or renal disease
- • Pregnancy
- • No access to telephone
- • Not able to come for follow up visit on day 3 or 4.
- • Already taking antibiotics at the time of presentation
- • Symptoms present for more than 2 weeks
- • Presence of any sign of severe diseases as defined by the British Thoracic Society modified CRP-65 system for severity scoring of pneumonia in primary care.
- • For children (Age ≥ 6 years and \< 16 years) additional exclusion criteria include: Tachypnea, signs of chest wall in drawing, reduced consciousness, confusion, dehydration, hypothermia, severe malnutrition, unable to feed or drink, vomiting, and convulsions.
About Oxford University Clinical Research Unit, Vietnam
The Oxford University Clinical Research Unit (OUCRU) in Vietnam is a leading institution dedicated to advancing medical knowledge and improving health outcomes through innovative clinical research. As part of a global network, OUCRU focuses on infectious diseases and public health challenges, leveraging its expertise to conduct high-quality clinical trials and epidemiological studies. With a commitment to ethical research practices and collaboration with local and international partners, OUCRU aims to translate scientific findings into effective interventions, contributing to the health and well-being of communities in Vietnam and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hanoi, , Vietnam
Patients applied
Trial Officials
Heiman FL Wertheim, M.D,Ph.D
Study Director
Oxford University Clinical Research Unit
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials